| dc.creator |
AKIN, Tezcan; Ankara Şehir Hastanesi |
|
| dc.creator |
OCAKLI, Serhat; SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ |
|
| dc.creator |
GÜNEŞ, Gizem; SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ |
|
| dc.creator |
DOĞAN, İbrahim; SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ |
|
| dc.creator |
AKIN, Merve; Ankara Şehir Hastanesi |
|
| dc.creator |
ÇETİNKAYA, Erdinç; Ankara Şehir Hastanesi |
|
| dc.creator |
BERKEM, Hüseyin; Ankara Şehir Hastanesi |
|
| dc.creator |
ER, Sadettin; Ankara Şehir Hastanesi |
|
| dc.creator |
TEZ, Mesut; Ankara Şehir Hastanesi |
|
| dc.date |
2021-09-13T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:47:06Z |
|
| dc.date.available |
2021-12-03T11:47:06Z |
|
| dc.identifier |
https://dergipark.org.tr/tr/pub/sdutfd/issue/64881/962273 |
|
| dc.identifier |
10.17343/sdutfd.962273 |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94277 |
|
| dc.description |
AmaçSon yıllarda sistemik inflamasyon skor (SIS) ve modifiyesistemik inflamasyon skor (mSIS) gibi skorlarınkolorektal kanserlerde prognostik ve prediktif değerleriaraştırılmıştır. Bu çalışmada, basit labaratuvartestleri ile hesaplanan modifiye sistemik inflamatuarskorun (mSIS) high grade displazili (HGD) kolonpoliplerinde invaziv karsinom varlığını öngörmedekietkinliği araştırıldı.Gereç ve YöntemOcak 2019 -Ekim 2021 tarihleri arasında preoperatifHGD tanısıyla opere edilen 44 kolorektal polipli hastanınpostoperatif verileri retrospektif olarak incelendi.Hastalar postoperatif histopatolojik inceleme sonuçlarınagöre HGD, Tis veya adenomatöz polip veinvaziv karsinom olarak iki gruba ayrıldı. mSIS hesaplaması;mSIS 0 [albümin (ALB) ≥ 4.0 g/dL ve lenfosit/monosit oranı (LMR) ≥ 3.4], mSIS 1 (ALB |
|
| dc.description |
ObjectiveIn recent years, the prognostic and predictive valuesof scoring systems such as systemic inflammationscore (SIS) and modified systemic inflammationscore (mSIS) have been investigated in colorectalcancers. To investigate the efficacy of the modifiedsystemic inflammatory score (mSIS) calculated bysimple laboratory tests in predicting the presence ofinvasive carcinoma in colon polyps with high-gradedysplasia (HGD).Materials and MethodsThe postoperative data of 44 patients with colorectalpolyps who underwent surgery with the diagnosisof preoperative HGD between January 2019 andOctober 2021 were retrospectively analyzed.According to the results of the postoperativehistopathological examination, the patients weredivided into two groups as HGD/intramucosalcarsinom (Tis)/adenomatous polyp and invasivecarcinoma. mSIS calculation was made as follows:mSIS 0 [albumin (ALB)≥4.0 g/dL and lymphocyte/monocyte ratio (LMR)≥3.4], mSIS 1 (ALB |
|
| dc.format |
application/pdf |
|
| dc.language |
en |
|
| dc.publisher |
Süleyman Demirel Üniversitesi |
|
| dc.publisher |
Süleyman Demirel University |
|
| dc.relation |
https://dergipark.org.tr/tr/download/article-file/1859285 |
|
| dc.source |
Volume: 28, Issue: 3
507-513 |
en-US |
| dc.source |
1300-7416 |
|
| dc.source |
2602-2109 |
|
| dc.source |
SDÜ Tıp Fakültesi Dergisi |
|
| dc.subject |
kolorektal konser,Modifiye sistemik inflamtuar skor,inflamatuar belirteçler,high-grade displazi |
|
| dc.subject |
High-grade dysplasia,Colorectal Carcinoma,Inflammatory markers,ModifiedSystemic Inflammation Score |
|
| dc.title |
MODİFİYE SİSTEMİK İNFLAMASYON SKORU YÜKSEK DERECE DİSPLAZİLİ KOLOREKTAL POLİPLERDE İNVAZİV KARSİNOM VARLIĞINI ÖNGÖRMEDE KULLANILABİLİR |
tr-TR |
| dc.title |
THE MODIFIED SYSTEMIC INFLAMMATION SCORE CAN BE USED TO PREDICT THE PRESENCE OF INVASIVE CARCINOMA IN COLORECTAL POLYPS WITH HIGH-GRADE DYSPLASIA |
en-US |
| dc.type |
info:eu-repo/semantics/article |
|
| dc.citation |
1. F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A.
Jemal, Global cancer statistics 2018: GLOBOCAN estimates of
incidence and mortality worldwide for 36 cancers in 185 countries,
CA: a cancer journal for clinicians, 68 (2018) 394-424. |
|
| dc.citation |
2. L.H. Nguyen, A. Goel, D.C. Chung, Pathways of colorectal carcinogenesis,
Gastroenterology, 158 (2020) 291-302. |
|
| dc.citation |
3. E. Gorgun, C. Benlice, J.M. Church, Does cancer risk in colonic
polyps unsuitable for polypectomy support the need for advanced
endoscopic resections? Journal of the American College of
Surgeons, 223 (2016) 478-484. |
|
| dc.citation |
4. O. Engin, Colon Polyps and Colorectal Cancer, Springer2020. |
|
| dc.citation |
5. J.H. Jang, E. Balik, D. Kirchoff, W. Tromp, A. Kumar, M. Grieco,
D.L. Feingold, V. Cekic, L. Njoh, R.L. Whelan, Oncologic
colorectal resection, not advanced endoscopic polypectomy, is
the best treatment for large dysplastic adenomas, Journal of
Gastrointestinal Surgery, 16 (2012) 165-172. |
|
| dc.citation |
6. S. Jones, W.-d. Chen, G. Parmigiani, F. Diehl, N. Beerenwinkel,
T. Antal, A. Traulsen, M.A. Nowak, C. Siegel, V.E. Velculescu,
Comparative lesion sequencing provides insights into tumor
evolution, Proceedings of the National Academy of Sciences,
105 (2008) 4283-4288. |
|
| dc.citation |
7. P.J. Pickhardt, B.D. Pooler, D.H. Kim, C. Hassan, K.A. Matkowskyj,
R.B. Halberg, The natural history of colorectal polyps:
overview of predictive static and dynamic features, Gastroenterology
Clinics, 47 (2018) 515-536. |
|
| dc.citation |
8. J.S. Levine, D.J. Ahnen, Adenomatous polyps of the colon,
New England Journal of Medicine, 355 (2006) 2551-2557. |
|
| dc.citation |
9. M. Climent, É.J. Ryan, Á. Stakelum, Y.L. Khaw, B. Creavin,
A. Lloyd, D. Alhassan, H.M. Mohan, R. Kennelly, K. Sheahan,
Systemic inflammatory response predicts oncological outcomes
in patients undergoing elective surgery for mismatch repair-
deficient colorectal cancer, International journal of colorectal
disease, 34 (2019) 1069-1078. |
|
| dc.citation |
10. Y. Suzuki, K. Okabayashi, H. Hasegawa, M. Tsuruta, K. Shigeta,
T. Kondo, Y. Kitagawa, Comparison of preoperative inflammation-
based prognostic scores in patients with colorectal
cancer, Annals of surgery, 267 (2018) 527-531. |
|
| dc.citation |
11. R.D. Dolan, S.T. McSorley, J.H. Park, D.G. Watt, C.S. Roxburgh,
P.G. Horgan, D.C. McMillan, The prognostic value of
systemic inflammation in patients undergoing surgery for colon
cancer: comparison of composite ratios and cumulative scores,
British journal of cancer, 119 (2018) 40-51. |
|
| dc.citation |
12. F. Wang, W. He, C. Jiang, G. Guo, B. Ke, Q. Dai, J. Long, L.
Xia, Prognostic value of inflammation-based scores in patients
receiving radical resection for colorectal cancer, BMC cancer,
18 (2018) 1-10. |
|
| dc.citation |
13. H. Ataş, B. Korukluoğlu, B.A. Özdemir, N. Yakşi, B. Saylam, M.
Tez, Diagnostic value of modified systemic inflammation score
for prediction of malignancy in patients with indeterminate
thyroid nodules, The American Journal of Surgery, 221 (2021)
117-121. |
|
| dc.citation |
14. J.-X. Lin, J.-P. Lin, J.-W. Xie, J.-b. Wang, J. Lu, Q.-Y. Chen, L.-l.
Cao, M. Lin, R. Tu, C.-H. Zheng, Prognostic importance of the
preoperative modified systemic inflammation score for patients
with gastric cancer, Gastric Cancer, 22 (2019) 403-412. |
|
| dc.citation |
15. H. AtaŞ, B. KorukluoĞlu, B. ÇomÇali, N. YakŞİ, B. Saylam, M.
Tez, Can preoperative modified systemic inflammation score
(mSIS) be used to predict malignancy in persistent nondiagnostic
thyroid nodules?, Turkish Journal of Medical Sciences,
(2021). |
|
| dc.citation |
16. T. Suzuki, Y. Ishibashi, H. Tsujimoto, S. Nomura, K. Kouzu, Y.
Itazaki, T. Sugihara, M. Harada, N. Ito, H. Sugasawa, A Novel
Systemic Inflammatory Score Combined With Immunoinflammatory
Markers Accurately Reflects Prognosis in Patients With
Esophageal Cancer, in vivo, 34 (2020) 3705-3711. |
|
| dc.citation |
17. M. Shibutani, K. Maeda, H. Nagahara, T. Fukuoka, S. Matsutani,
K. Kimura, R. Amano, K. Hirakawa, M. Ohira, The prognostic
value of the systemic inflammatory score in patients with
unresectable metastatic colorectal cancer, Oncology letters, 16
(2018) 666-672. |
|
| dc.citation |
18. S. Rüth, J. Spatz, M. Anthuber, Is There an Indication for Surgical
Resection in Colorectal Adenoma?, Visceral Medicine, 30
(2014) 46-51. |
|
| dc.citation |
19. R. Rodrigues, S. Geyl, J. Albouys, C. De Carvalho, M. Crespi,
T. Tabouret, A. Taibi, S. Durand-Fontanier, R. Legros, M.
Dahan, Effect of implementing a regional referral network on
surgical referral rate of benign polyps found during a colorectal
cancer screening program: A population-based study, Clinics
and Research in Hepatology and Gastroenterology, 45 (2021)
101488. |
|
| dc.citation |
20. A. Emmanuel, S. Gulati, M. Burt, B.H. Hayee, A. Haji, Colorectal
endoscopic submucosal dissection: patient selection and
special considerations, Clinical and experimental gastroenterology,
10 (2017) 121. |
|
| dc.citation |
21. S. Tanaka, H. Kashida, Y. Saito, N. Yahagi, H. Yamano, S. Saito,
T. Hisabe, T. Yao, M. Watanabe, M. Yoshida, JGES guidelines
for colorectal endoscopic submucosal dissection/endoscopic
mucosal resection, Digestive Endoscopy, 27 (2015) 417-434. |
|
| dc.citation |
22. J.M. McDonald, R. Moonka, R.H. Bell Jr, Pathologic risk factors
of occult malignancy in endoscopically unresectable colonic
adenomas, The American journal of surgery, 177 (1999) 384-
387. |
|
| dc.citation |
23. R. Loungnarath, M.G. Mutch, E.H. Birnbaum, T.E. Read, J.W.
Fleshman, Laparoscopic colectomy using cancer principles is
appropriate for colonoscopically unresectable adenomas of the
colon, Diseases of the colon & rectum, 53 (2010) 1017-1022. |
|
| dc.citation |
24. L. Bujanda, A. Cosme, I. Gil, J.I. Arenas-Mirave, Malignant
colorectal polyps, World journal of gastroenterology: WJG, 16
(2010) 3103. |
|
| dc.citation |
25. T. Yao, S. Shiono, Differences in the pathological diagnosis of
colorectal neoplasia between the East and the West: Present
status and future perspectives from Japan, Digestive Endoscopy,
28 (2016) 306-311. |
|
| dc.citation |
26. H. Ikematsu, Y. Yoda, T. Matsuda, Y. Yamaguchi, K. Hotta, N.
Kobayashi, T. Fujii, Y. Oono, T. Sakamoto, T. Nakajima, Longterm
outcomes after resection for submucosal invasive colorectal
cancers, Gastroenterology, 144 (2013) 551-559. |
|